Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 2267 Lung Neoplasms 1050 Small Cell Lung Carcinoma 403 Adenocarcinoma of Lung 155 Mesothelioma, Malignant 120 Breast Neoplasms 110 Neoplasms 106 Brain Neoplasms 101 Neoplasm Metastasis 95 Melanoma 72 Mesothelioma 70 NSCLC 69 Colorectal Neoplasms 69 Adenocarcinoma, Bronchiolo-Alveolar 56 Thymoma 53 Pancreatic Neoplasms 52 Head and Neck Neoplasms 47 Ovarian Neoplasms 46 Carcinoma, Renal Cell 43 Carcinoma 39 Stomach Neoplasms 36 Prostatic Neoplasms 36 Sarcoma 35 Esophageal Neoplasms 35 Uterine Cervical Neoplasms 34 Squamous Cell Carcinoma of Head and Neck 34 Adenocarcinoma 34 Pleural Effusion, Malignant 33 Recurrence 27 Urinary Bladder Neoplasms 26

Interventions

adagrasib 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Resectable Non-Small Cell Lung Cancer × Thoracic × Clear all

NCT05472623 2025-09-15

Neo-Kan

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Withdrawn

Resectable Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡